Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study
Psilocybin reduced neural responses to surprising tactile stimuli, decreasing activity in frontal regions, visual cortex and cerebellum and attenuating frontal tactile mismatch negativity, consistent with aberrant prediction‑error processing and 5‑HT2A‑mediated disruption of bodily‑self integration. These findings link altered tactile deviancy processing to changes in self‑experience and suggest relevance for psychiatric disorders characterised by aberrant bodily self‑awareness.
Authors
- Franz Vollenweider
- Katrin Preller
- Philipp Stämpfli
Published
Abstract
As source of sensory information, the body provides a sense of agency and self/non-self-discrimination. The integration of bodily states and sensory inputs with prior beliefs has been linked to the generation of bodily self-consciousness. The ability to detect surprising tactile stimuli is essential for the survival of an organism and for the formation of mental body representations. Despite the relevance for a variety of psychiatric disorders characterized by altered body and self-perception, the neurobiology of these processes is poorly understood. We therefore investigated the effect of psilocybin (Psi), known to induce alterations in self-experience, on tactile mismatch responses by combining pharmacological manipulations with simultaneous electroencephalography–functional magnetic resonance imaging (EEG–fMRI) recording. Psi reduced activity in response to tactile surprising stimuli in frontal regions, the visual cortex, and the cerebellum. Furthermore, Psi reduced tactile mismatch negativity EEG responses at frontal electrodes, associated with alterations of body- and self-experience. This study provides first evidence that Psi alters the integration of tactile sensory inputs through aberrant prediction error processing and highlights the importance of the 5-HT2A system in tactile deviancy processing as well as in the integration of bodily and self-related stimuli. These findings may have important implications for the treatment of psychiatric disorders characterized by aberrant bodily self-awareness.
Research Summary of 'Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study'
Introduction
The skin provides the primary interface between the body and environment and plays a central role in boundary processing and self/non-self discrimination. Disruption of multisensory integration that supports bodily self-awareness is implicated in several psychiatric disorders. Within a predictive coding framework, the brain minimises surprise by comparing incoming sensory input with top-down priors; prediction error (PE) signals arising from mismatches drive updating of internal models. The mismatch negativity (MMN) event-related potential is an index of early PE and perceptual learning and has been linked to altered sensory processing in conditions such as schizophrenia. Serotonergic psychedelics, including psilocybin (Psi), act primarily at 5-HT2A receptors and produce dose-dependent, reversible alterations in self- and body-perception, making them useful probes of the neurobiology of bodily awareness. Duerler and colleagues set out to test whether psilocybin alters the neural processing of tactile surprising stimuli and whether such changes relate to subjective alterations in body and self-experience. Using a simultaneous EEG–fMRI design and a roving somatosensory oddball task, the investigators hypothesised that Psi (versus placebo) 1) changes blood-oxygen-level-dependent (BOLD) responses in regions implicated in tactile deviancy processing, 2) reduces the EEG MMN amplitude to tactile deviants, and 3) that these neural changes correlate with self-reported alterations in body and self-experience. The study aimed to link spatial (fMRI) and temporal (EEG) markers of tactile PE processing under 5-HT2A stimulation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Duerler, P., Brem, S., Fraga-González, G., Neef, T., Allen, M., Zeidman, P., Stämpfli, P., Vollenweider, F. X., & Preller, K. H. (2021). Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study. Cerebral Cortex, 32(1), 186-196. https://doi.org/10.1093/cercor/bhab202
References (18)
Papers cited by this study that are also in Blossom
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Bravermanová, A., Viktorinová, M., Tylš, F. et al. · Psychopharmacology (2018)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Halberstadt, A. L., Geyer, M. A. · Neuropharmacology (2011)
Kometer, M., Schmidt, A., Bachmann, R. et al. · Biological Psychiatry (2012)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Preller, K. H., Razi, A., Zeidman, P. et al. · PNAS (2019)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Show all 18 referencesShow fewer
Quednow, B. B., Kometer, M., Geyer, M. A. et al. · Neuropsychopharmacology (2011)
Rucker, J., Young, A. H., Jelen, L. A. et al. · Journal of Psychopharmacology (2016)
Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)
Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)
Timmermann, C., Spriggs, M. J., Kaelen, M. et al. · Neuropharmacology (2018)
Umbricht, A., Vollenweider, F. X., Schmid, L. et al. · Neuropsychopharmacology (2003)
Vollenweider, F. X., Leenders, K. L., Maguire, P. et al. · Neuropsychopharmacology (1997)
Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)
Cited By (9)
Papers in Blossom that reference this study
Dor-Ziderman, Y., David, J., Berkovich-Ohana, A. · Psychopharmacology (2025)
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Hutten, N. R. P. W., Quaedflieg, C. W. E. M., Mason, N. L. et al. · Translational Psychiatry (2024)
Casanova, A. F., Ort, A., Smallridge, J. W. et al. · iScience (2024)
De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)
Rieser, N. M., Gubser, L. P., Moujaes, F. et al. · Scientific Reports (2023)
Mallaroni, P., Mason, N. L., Reckweg, J. T. et al. · Clinical Pharmacology and Therapeutics (2023)
Whelan, T. P., Daly, E., Puts, N. A. et al. · MedRvix (2023)
Vollenweider, F. X., Smallridge, J. W. · Pharmacopsychiatry (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.